Arcadia Biosciences Inc (RKDA) Stock Analysis
Verdict: AVOID
Terminal liquidity crisis and a 93% price collapse override recent EPS beats, signaling a high probability of total equity wipeout.
Investment score: 18/100
Analysis as of
Is Arcadia Biosciences Inc stock worth reviewing? AI model thesis
Arcadia Biosciences is in a state of financial distress with a market cap of $1.5M and a cash balance that cannot sustain operations through the next quarter. The recent 26% one-day drop reflects a loss of investor confidence in the turnaround plan despite narrowing losses.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 35/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
Arcadia Biosciences Inc opportunities and risks
What speaks for RKDA
- Asset Monetization Potential
What speaks against RKDA
- Immediate Liquidity Exhaustion
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| RKDA | n/a | 0.1x | n/a | 34.6% | -234.5% | -371.1% |
| SDOT | n/a | 0.1x | n/a | -1.3% | -86.4% | -25.6% |
| HERB | 0.4x | 0.1x | n/a | 33.5% | 33.4% | 83.0% |
| EDBL | n/a | 0.0x | n/a | -34.4% | -122.1% | -4186.6% |
| AAGR | n/a | 0.2x | n/a | 25.2% | -2369.4% | -983.4% |
| STEV | n/a | 0.0x | n/a | 0.0% | 0.0% | -32.1% |
| Peer median | n/a | 0.1x | n/a | 0.0% | -86.4% | -32.1% |
Frequently asked questions about Arcadia Biosciences Inc (RKDA)
Is RKDA stock a good investment?
The cached TradeMates AI model rates Arcadia Biosciences Inc as AVOID with an investment score of 18/100. Arcadia Biosciences is in a state of financial distress with a market cap of $1.5M and a cash balance that cannot sustain operations through the next quarter. The recent 26% one-day drop reflects a loss of investor confidence in the turnaround plan despite narrowing losses. This is algorithmic model output, not personal investment advice.
Is RKDA stock a buy?
The TradeMates model verdict for RKDA is AVOID with an investment score of 18/100. Treat this as a model signal to review, not a personal buy recommendation.